Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study

The Lancet HIV · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles